Skip to content
TrackPodcasts
scienceAug 29, 20241:43pending

Trailer: The Devil in the Details

Get every episode summarized

Each time Lost Women of Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

About this episode

In the 1950s, a German drug company developed a new sedative that was supposed to be 100% safe: thalidomide. So safe, in fact, it was promoted to women as a treatment for morning sickness. It quickly became a bestseller. But in the early 1960s, shocking news started coming out of Europe. Thousands of babies were being born with shortened arms and legs, heart defects, and other serious problems. Many died. 

In the United States things were different, thanks to one principled, strong-minded skeptic who joined the Federal Drug Administration in 1960 as a medical reviewer. One of her first assignments was to review the approval application of that very wonder drug, thalidomide. But the application was, to her mind, flawed. 

Dr. Frances Oldham Kelsey was a physician, a pharmacologist, and a nitpicker who refused to be intimidated by big pharma.

Starting in September, a new five-part series from Lost Women of Science: The Devil in the Details, the story of Frances Oldham Kelsey, The Doctor Who Said No To Thalidomide. 


Learn about your ad choices: dovetail.prx.org/ad-choices

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Trailer: The Devil in the Details

Lost Women of Science

0:00
1:43

More episodes

More from Lost Women of Science

View all episodes →